Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
about
A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytesRoles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related DiseasesAPOBEC3 Interference during Replication of Viral GenomesRole of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates.Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.Treating cancer as an infectious disease--viral antigens as novel targets for treatment and potential prevention of tumors of viral etiologyHuman T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.Hematopoietic stem cells and retroviral infection.Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivoMolecular epidemiology of simian T-cell lymphotropic virus type 1 in wild and captive sooty mangabeys.Early spatial and temporal events of human T-lymphotropic virus type 1 spread following blood-borne transmission in a rabbit model of infection.Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosisHTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motifHTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-IEvaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation.HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemiaThe HTLV-1 Tax oncoprotein represses Ku80 gene expression.Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriersDurable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.Adult T cell leukemia lymphoma.Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.Imaging virus-associated cancer.Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.Early and transient reverse transcription during primary deltaretroviral infection of sheep.Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinaseCellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversionHuman T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes.A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep.Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
P2860
Q25256930-149C9BB1-DBD7-4CF6-96FF-F75F60D8CAE8Q26774352-A2FE1BB6-8E43-44E1-A907-38B073E1824CQ28081195-1E02C4FD-76E0-424B-B380-81110BD4545BQ33206633-C3348271-6DF4-4106-BEA4-BBBA6736BE97Q33244717-42E4259B-4B2E-4470-A98B-44C2AE82D816Q33247311-A39D486B-0BED-4798-A491-E247E253130DQ33304454-0E32C260-6348-43A8-BA13-2AFAA4BD3F26Q33407197-0C14A0BE-C466-4566-BCB1-20FBF87D9790Q33627019-F2BEB9E6-67E4-441A-8033-0CBFEB04CFBAQ33677922-5BDE50B7-98D1-40B9-AB7A-AE212CF5FABBQ33758754-3B320F02-9283-46F8-8FBD-8C9FCD1F4A96Q33781184-CA7AEC7A-D4C4-42D6-B974-141111F9CE26Q33826877-C9956ED0-3FFD-4965-90D8-130DAD8D1735Q33908852-A97A17A6-38F0-4B03-807E-54FFAFD8E318Q33946851-02E6AA91-50D2-48A9-AE67-81E4D120A45FQ34059240-681FDE06-85D7-49E6-AE54-3BA05C0666BEQ34498932-AB35E360-C04A-4F42-88C9-B69F69C28D0FQ34545731-D61FF983-257C-4F7A-AAC2-37899914D20EQ34562309-EDD8F112-CD19-46F8-93DE-0F3C97B91BCFQ34567129-4181DFA4-98CE-4BB3-A95E-647F5107FA4EQ34941861-A1D597A4-2526-44C6-AE59-B7EDCAE55DCDQ35038711-E286B667-25ED-4E0C-930E-795D5105205CQ35138158-DD9DEA3F-6993-4813-B44F-0C341D048A0FQ35780796-BAE89C22-E69B-46A0-9E17-773C4E626673Q35847654-06FCA7B9-2BD5-47BC-8A21-708F72A9070EQ35847684-4FB78D96-2432-4F65-9087-6D171AE2103EQ35880693-2B3EA27C-882C-4892-835B-908ABB9E2122Q35920356-AED8DC29-ABE3-4EE8-8404-CAAC2D70D88CQ36015054-93F36699-1F4D-4CB9-A1C4-F1C1C8746EE8Q36104480-957042E2-1B6D-4478-85B2-9A0B1B5BE85AQ36254880-21748452-0D69-4AC3-A889-231380529ABEQ36502550-C152B6EF-E235-4DD9-9C41-F82F3A85FC9DQ36932981-1F123B71-3734-48B5-86D8-CBB75E6D21DCQ37008651-727D059B-E0A6-4034-9488-6B44770B68D3Q37021560-11CB890A-8D13-4D30-94CE-FBE9B86BD9AFQ37069833-1674B4D6-F404-4080-BA22-643EF582C69CQ37093163-EBC00449-EFA3-4CFB-894A-F61C20A2B5B2Q37156360-862C17CC-3DCD-419C-A337-1EC9494CB6A7Q37161179-19B615E6-8C67-4072-95B4-522EDBD87CDAQ37241473-A1C4F3DD-6A93-4AE6-8DF4-BC306E967A6E
P2860
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
@en
type
label
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
@en
prefLabel
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
@en
P2093
P2860
P356
P1433
P1476
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
@en
P2093
P2860
P2888
P356
10.1038/SJ.LEU.2402777
P577
2003-01-01T00:00:00Z